Elevated levels of monocyte chemoattractant protein-1 in postmenopausal women -: Effect of hormone replacement therapy

被引:0
|
作者
Brückmann, M
Salbach, B
Lang, S
von Holst, T
Kübler, W
Salbach, PB
机构
[1] Univ Heidelberg, Dept Cardiol, Heidelberg, Germany
[2] Univ Heidelberg, Dept Gynaecol, Heidelberg, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:254A / 254A
页数:1
相关论文
共 50 条
  • [1] Effects of hormone replacement therapy on serum monocyte chemoattractant protein-1 in postmenopausal women
    Stork, S
    Baumann, K
    Kiefl, R
    Angerer, P
    von Schacky, C
    CIRCULATION, 1998, 98 (17) : 385 - 385
  • [2] Effect of hormone replacement therapy on nitric oxide bioactivity and monocyte chemoattractant protein-1 levels
    Koh, KK
    Son, JW
    Ahn, JY
    Lee, SK
    Hwang, HY
    Kim, DS
    Jin, DK
    Ahn, TH
    Shin, EK
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2001, 81 (01) : 43 - 50
  • [3] Effect of transdermal hormone replacement therapy on the monocyte chemoattractant protein-1 concentrations and other vascular inflammatory markers and on endothelial function in postmenopausal women
    Sumino, H
    Ichikawa, S
    Ohyama, Y
    Takahashi, T
    Saito, Y
    Nakamura, T
    Kanda, T
    Kurabayashi, M
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (01): : 148 - 153
  • [4] Raloxifene reduces circulating levels of interleukin-7 and monocyte chemoattractant protein-1 in postmenopausal women
    Yasui, Toshiyuki
    Uemura, Hirokazu
    Hyodo, Sari
    Yamada, Masayo
    Yamamoto, Satoshi
    Maegawa, Masahiko
    Tsuchiya, Naoko
    Noguchi, Masamichi
    Yuzurihara, Mitsutoshi
    Kase, Yoshio
    Irahara, Minoru
    ATHEROSCLEROSIS, 2009, 204 (02) : 471 - 475
  • [5] Elevated Levels of Monocyte Chemoattractant Protein-1 in the Aqueous Humor after Phacoemulsification
    Kawai, Motofumi
    Inoue, Toshihiro
    Inatani, Masaru
    Tsuboi, Naoko
    Shobayashi, Kohei
    Matsukawa, Akihiro
    Yoshida, Akitoshi
    Tanihara, Hidenobu
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2012, 53 (13) : 7951 - 7960
  • [6] Effects of transdermal and oral hormone replacement therapies on monocyte chemoattractant protein-1 levels: a randomized clinical trial
    Tasci, Tolga
    Sukur, Yavuz Emre
    Ozmen, Batuhan
    Atabekoglu, Cem Somer
    Cengiz, Sevim Dincer
    Kocbulut, Evren
    Berker, Bulent
    Sonmezer, Murat
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2014, 176 : 50 - 54
  • [7] Epoprostenol therapy decreases elevated circulating levels of monocyte chemoattractant protein-1 in patients with primary pulmonary hypertension
    Hashimoto, K
    Nakamura, K
    Fujio, H
    Miyaji, K
    Morita, H
    Kusano, K
    Date, H
    Shimizu, N
    Emori, T
    Matsubara, H
    Ohe, T
    CIRCULATION JOURNAL, 2004, 68 (03) : 227 - 231
  • [8] Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty
    Ikeda, U
    Shimada, K
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (06) : 1090 - 1090
  • [9] Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty
    Cipollone, F
    Marini, M
    Fazia, M
    Pini, B
    Iezzi, A
    Reale, M
    Paloscia, L
    Materazzo, G
    D'Annunzio, E
    Conti, P
    Chiarelli, F
    Cuccurullo, F
    Mezzetti, A
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (03) : 327 - 334
  • [10] Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease
    Martinovic, I
    Abegunewardene, N
    Seul, M
    Vosseler, M
    Horstick, G
    Buerke, M
    Darius, H
    Lindemann, S
    CIRCULATION JOURNAL, 2005, 69 (12) : 1484 - 1489